Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 3

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(2)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07561840Not ApplicableNot Yet Recruiting

Exercise Training After Upper Gastrointestinal Cancer Surgery

Role: lead

NCT03331718Phase 3Completed

PoLyglycolic Acid Felt reiNforcEmenT of the PancreaticoJejunostomy (PLANET-PJ Trial)

Role: collaborator

NCT04066868Not ApplicableCompleted

Evaluating the Use of Patient-Reported Outcome Measures for Improving the Inter-Rater Reliability of Common Terminology Criteria for Adverse Event Ratings

Role: collaborator

NCT06447532Enrolling By Invitation

Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients

Role: collaborator

NCT03506113Phase 4Completed

GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial

Role: collaborator

NCT04018235Completed

Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast Cancer

Role: collaborator

NCT00436111Completed

Characterization of Macroprolactinemia

Role: lead

All 7 trials loaded